CHINA PHARMA HOLDINGS, INC. Payments for Loans
CHINA PHARMA HOLDINGS, INC. (CPHI) had Payments for Loans of $1.85 million as of 2023-08-23, per its 10-K filed 2024-04-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForLoans · last filed 2025-11-12
- 2023-08-23: Payments for Loans $1.85M; Payments for Loans as first filed $1.35M.
- 2019-07-08: Payments for Loans $738.38K.
USD
| Period end | Payments for Loans | Payments for Loans as first filed |
|---|---|---|
| 2023-08-23 | $1.85M 10-K · filed 2024-04-01 | $1.35M 10-Q · filed 2023-11-13 |
| 2019-07-08 | $738.38K 10-Q · filed 2025-11-12 |
CNY
| Period end | Payments for Loans |
|---|---|
| 2019-07-08 | 4.77M CNY 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |